This Blanket Purchase Agreement (BPA) contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to International Business Machines Corporation (IBM) as the prime contractor. The contract has a ceiling value of $163,000,000 and a performance period through March 29, 2025. Under this BPA, IBM will provide a range of regulatory review support services to the FDA, including data management, analysis, standards development, and system modernization. Multiple task orders have been issued to IBM, valued at over $60 million, to deliver specific services such as data quality assurance, clinical data safety analysis, data standards testing, and regulatory submission support across the FDA's Centers for Drug Evaluation and Research, Cosmetics and Colors, and Tobacco Products. IBM has subcontracted portions of the work to several small and minority-owned businesses to provide specialized computer programming and IT services in support of the FDA's mission-critical initiatives.
The original solicitation was issued by the General Services Administration's Federal Acquisition Service for the IT Schedule 70 contract vehicle, which provides federal agencies access to a broad range of commercial information technology products and services. The BPA was established under Schedule 70 to enable the FDA to efficiently procure the necessary technology solutions and subject matter expertise to support its regulatory review activities. While no small business set-asides were used, IBM has demonstrated a track record of partnering with small and disadvantaged firms as subcontractors on these types of federal contracts.
Generated 8/6/24, 10:18 AM